The condition for Prescribed List reimbursement of surgical guides and biomodels is now effective (1 February 2024).
We have updated the Frequently Asked Questions (FAQ) document to clarify stakeholder questions around, particularly around inclusion of an MBS item description.
The department will continue to assess and consider stakeholder feedback on the matter, and maintain regular dialogue with private health insurance and private hospital representatives. Any further changes resulting from the above will be reflected via an updated FAQ document.